Breakpoints cover image

#109 – IDWeek 2024 Recap: Practice Changing Papers and ID Potpourri

Breakpoints

00:00

Innovative Therapies for EBV-Positive Post-Transplant Complications

This chapter explores cutting-edge treatments for Epstein-Barr virus-related post-transplant lymphoproliferative disorder, focusing on new trials for EBV-specific T-cell therapies. It discusses the effectiveness, safety, and future prospects of these therapies while addressing existing challenges in their approval and availability.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner
Get the app